Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4E6M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,696
Award facts
- Contract value 100% obligated
- $88,695.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $88.7K to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, firm fixed-price delivery order represents a child task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $1 billion ceiling value through December 2026. The contract involves no set-aside designation, indicating full and open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with performance occurring at its corporate office location in Pennsylvania.
This award supports the Defense Logistics Agency's Medical Supply Chain operations, enabling the delivery of Dupixent—a biologic immunosuppressant used primarily for eczema, asthma, and other inflammatory conditions—to military treatment facilities and other federal healthcare entities. AmerisourceBergen's role as a prime vendor under the DLA pharmaceutical program reflects its established capability to fulfill complex federal medical procurement requirements across multiple therapeutic domains, ranging from specialty biologics to generic medications and medical supplies. The delivery order carries an ultimate completion date of January 8, 2026, representing a rapid fulfillment timeframe typical of pharmaceutical supply chain operations supporting active military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F4E6M?
SPE2DR26F4E6M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4E6M worth?
The government has obligated $88,696 on SPE2DR26F4E6M.
Is contract SPE2DR26F4E6M an order under another contract?
Yes. SPE2DR26F4E6M is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E6M competed?
The extent of competition for SPE2DR26F4E6M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award